Public procurement notice: Contract Award Notice
Published: 2017-12-02
Buyer: The Common Services Agency (more commonly known as NHS National Services Scotland) (‘the Authority’)
Country: UK
Contract type: Supplies
Procedure: Open procedure
CPV classification: 33600000: Pharmaceutical products | 33696100
Estimated value: 7566060 GBP
Award criteria: The most economic tender

Technical requirements: This Framework Agreement is awarded for the supply of a range of Erythropoietin Stimulating Agents and Sevelamer to Health Boards across NHS Scotland and the provision of a Home Delivery Service for the delivery of Erythropoietin Stimulating Agents Medicines to patient homes across NHS Scotland.
The framework agreement is awarded as a single supplier framework on a line by line basis for each product line.
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
This Framework Agreement is awarded for the supply of the range of Erythropoietin Stimulating Agents supplied by homecare delivery to patients across NHS Scotland.
Each product line is treated as an individual Lot and is awarded on a line by line basis. Each Lot is awarded as a single supplier framework agreement.
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
This Framework Agreement is awarded for the supply of the range of Erythropoietin Stimulating Agents to Health Boards across NHS Scotland.
Each product line is treated as an individual Lot and is awarded on a line by line basis. Each Lot is awarded as a single supplier framework agreement.
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
This framework agreement is awarded for the supply of Sevelamer Hydrochloride 800mg tablets, Sevelamer Carbonate 800mg tablets, and Sevelamer Carbonate 2.4G powder for oral suspension to NHS Scotland.
Each product line is treated as an individual Lot and is awarded on a line by line basis. Each Lot is awarded as a single supplier framework agreement.
The estimated value range referred to in Sections II.I.7 and V.2.4 (Lot 1, Lot 2 and Lot 3) covers the twenty four (24) months initial duration and the full two (2) periods of twelve (12) month extension options.
The bringing of court proceedings against the Authority during the standstill period will automatically continue the prohibition on entering into the framework agreement until the court proceedings are determined, discontinued or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include the setting aside of the decision to award the framework agreement to the winning tenderer(s). The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.


Winner: Teva UK Limited
Award value: 7566060
Number of bids: 2